Leustatin Related Clinical Trials
Allogeneic Transplantation Using Timed Sequential Busulfan, Cladribine, and Fludarabine Conditioning in Patients With Acute Myelogenous Leukemia (AML) and Myelodysplastic Syndrome (MDS) [Recruiting]
Cladribine Plus Idarubicin Plus Cytarabine (ARAC) in Patients With Acute Myeloid Leukemia (AML), High Risk Myelodysplastic Syndrome (HR MDS) or Myeloid Blast Phase of Chronic Myeloid Leukemia (CML) [Recruiting]
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) [Recruiting]
2CDA With Rituximab in Hairy Cell Leukemia [Recruiting]
Treatment of Macroglobulinemic Lymphoma With 2CdA, Cyclophosphamide and Rituximab [Active, not recruiting]
2-Chlorodeoxyadenosine and Cytarabine in Patients With Idiopathic Hypereosinophilic Syndrome (HES) [Completed]
4-Arm Phase II Study of SGI-110 in Elderly Acute Myeloid Leukemia (AML) [Recruiting]
R-2cda and Prolongation of Therapy With Rituximab Alone in Chronic Lymphocytic Leukaemia and Small Lymphocytic Lymphoma [Recruiting]
Bortezomib, Cladribine, and Rituximab in Treating Patients With Advanced Mantle Cell Lymphoma or Indolent Lymphoma [Active, not recruiting]
Vorinostat, Cladribine, and Rituximab in Treating Patients With Mantle Cell Lymphoma, Relapsed Chronic Lymphocytic Leukemia, or Relapsed B Cell Non-Hodgkin's Lymphoma [Active, not recruiting]
Filgrastim, Cladribine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With Newly Diagnosed or Relapsed/Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndromes [Recruiting]
Study Assessing the Interaction of Pantoprazole With Cladribine in Subjects With Multiple Sclerosis [Completed]
Bortezomib (VELCADE), Cladribine and Rituximab (VCR) in Mantle Cell Lymphoma (PSHCI 10-011) [Recruiting]
Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia [Recruiting]
Prospective Observational Long-term Safety Registry of Multiple Sclerosis Patients Who Have Participated in Cladribine Clinical Trials [Recruiting]
Oral Cladribine in Early Multiple Sclerosis (MS) [Completed]
Therapy Optimisation for the Treatment of Hairy Cell Leukemia [Recruiting]
Rituximab Plus 2CdA in Patients With Advanced or Relapsed Mucosa Associated Lymphoid Tissue (MALT) Lymphoma [Completed]
A Safety and Efficacy Study of Oral Cladribine in Subjects With Relapsing-remitting Multiple Sclerosis (RRMS) [Completed]
Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia With Cladribine Plus Rituximab [Completed]
Cladribine Based Induction Therapy With All-Trans Retinoic Acid and Midostaurin in Relapsed/Refractory AML [Completed]
Evaluation of Efficacy and Tolerance of Cladribine in Symptomatic Pulmonary Langerhans Cell Histiocytosis [Recruiting]
Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML) [Recruiting]
Rituximab and Cladribine in Treating Patients With Newly Diagnosed Non-Hodgkin's Lymphoma [Completed]
Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma [Active, not recruiting]
Cladribine in Patients With Mantle Cell Lymphoma [Completed]
CLARITY Extension Study [Completed]
Cladribine Plus Pegylated Interpheron Alfa-2a in Systemic Mastocytosis [Recruiting]
Cladribine and Rituximab as Remission Induction Therapy Followed By Rituximab and Stem Cell Mobilization in Treating Patients With CLL [Completed]
Daily or Weekly Cladribine in Treating Patients With Hairy Cell Leukemia [Completed]
LCH-IV, International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis [Recruiting]
Bryostatin 1 Plus Cladribine in Treating Patients With Relapsed Chronic Lymphocytic Leukemia [Completed]
Study of CLAG + Selinexor in Relapsed or Refractory Acute Myeloid Leukemia [Recruiting]
Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [Completed]
Peripheral Stem Cell Transplantation Plus Filgrastim in Treating Patients With Acute or Chronic Myelogenous Leukemia [Completed]
Cladribine, Cytarabine, and Imatinib Mesylate in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Blastic Phase Chronic Myelogenous Leukemia [Completed]
Trial of Cladribine, Cytarabine, Mitoxantrone, Filgrastim (CLAG-M) in Relapsed Acute Lymphoblastic Leukemia [Recruiting]
Phase II Pilot Study of Cladribine (2-Chlorodeoxyadenosine; 2-CdA) for Early Stage Primary Sclerosing Cholangitis [Completed]
A Study of Maintenance Treatment With MabThera (Rituximab) in Patients With Progressive B-cell Chronic Lymphocytic Leukemia [Active, not recruiting]
Nonmyeloablative Allogeneic Transplant [Recruiting]
Chemotherapy Followed by Radiation Therapy in Treating Patients With Malignant Glioma [Completed]
Idarubicin Plus Cytarabine (IA) vs IA Plus Cladribine (IAC) as Induction Regimen to Treat Initially Diagnosed Acute Myeloid Leukemia (AML) [Not yet recruiting]
Rituximab in Treating Patients With Refractory or Recurrent Hairy Cell Leukemia Following Cladribine Therapy [Completed]
Therapy-Optimization Trial for the Treatment of Acute Myeloid Leukemias (AML) in Children and Adolescents [Active, not recruiting]
Trial to Test the Effects of Adding 1 of 2 New Treatment Agents to Commonly Used Chemotherapy Combinations [Not yet recruiting]
Low Dose CdA Combined With Valproic Acid (VPA) in Previously Treated B-cell Chronic Lymphocytic Leukemia(B-CLL) [Recruiting]
A Study Evaluating the Effects of CLAG With Gleevec in Refractory or Relapsed Acute Myeloid Leukemia [Withdrawn]
BL22 Immunotoxin in Treating Patients Previously Treated With Cladribine for Hairy Cell Leukemia [Completed]
Treatment of Relapsed T-Cell Acute Lymphoblastic Leukemia or T-Lymphoblastic Lymphoma With MabCampath [Completed]
CLAG Gleevec in Relapsed or Refractory Acute Myeloid Leukemia (AML) [Completed]
Clofarabine in Chronic Lymphocytic Leukemia [Completed]
German Multicenter Trial for the Treatment of Newly Diagnosed T-lymphoblastic Lymphoma in Adults [Completed]
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (07/2003) [Recruiting]
Stem Cell Transplantation in Treating Patients With Hematologic Cancer [Completed]
Treatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia [Completed]
Unrelated Donor Stem Cell Transplantation [Recruiting]
Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma [Terminated]
Use of Tamoxifen in Systemic Mastocytosis [Recruiting]
Dose Escalation of Clofarabine in Combination With Cytarabine and Idarubicin as Induction Therapy in High Risk AML [Recruiting]
A Phase II Efficacy Study of Roferon-A in Hairy Cell Leukemia [Completed]
Phase II Study of Clofarabine in Patients With Recurrent or Refractory Langerhans Cell Histiocytosis [Not yet recruiting]
Low-dose Oral Clofarabine for the Treatment of IPSS INT-1, INT-2 or HIGH Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia [Completed]
Study Evaluating Temsirolimus (CCI-779) In Mantle Cell Lymphoma (MCL) [Completed]
|